Browse Categories

Transcatheter tricuspid valve replacement using the LuX-Valve Plus system: 1-year compassionate use outcomes.

Lukas Stolz , Neil Fam , Geraldine Ong , Pedro Villablanca , Ahmad Jabri , Ole de Backer , Jacob Eifer Mølller , Didier Tchétché , Omar Oliva , Kent Chak-Yu So , Yat-Yin Lam , Azeem Latib , Andrea Scotti , Augustin Coisne , Arnaud Sudre , Julien Dreyfus , Mohammed Nejjari , Ignacio Cruz-Gonzalez , Rodrigo Estévez-Loureiro , Manuel Barreiro-Perez

Eur J Heart Fail

Medizinische Klinik und Poliklinik I, LMU Klinikum, Munich, Germany.

Published: August 2025

Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Download full-text PDF

 Source
http://dx.doi.org/10.1002/ejhf.70010DOI Listing

Publication Analysis

Top Keywords

transcatheter tricuspid
4
tricuspid valve
4
valve replacement
4
replacement lux-valve
4
lux-valve system
4
system 1-year
4
1-year compassionate
4
compassionate outcomes
4
transcatheter
1
valve
1

Similar Publications

Performance of the TRI-SCORE in a Multicenter Cohort Undergoing Transcatheter Tricuspid Valve Repair and Replacement.

JACC Cardiovasc Interv

September 2025

Max Potratz , Akhil Narang , Muhammed Gerçek , Felix Rudolph , Mohammad Kassar

View Article and Find Full Text PDF
Similar Publications

Live three-dimensional multiplanar-reconstruction for advanced guidance of transcatheter tricuspid valve-in-valve procedure.

J Invasive Cardiol

September 2025

Division of Cardiology, Mount Sinai Heart Fuster Hospital, Icahn School of Medicine at Mount Sinai, New York, New York. Email:

Giulia Passaniti , Sahil Khera , Rajeev R Samtani , Stamatios Lerakis , Gilbert H L Tang

View Article and Find Full Text PDF
Similar Publications

Transcatheter Tricuspid Valve Interventions to Manage Tricuspid Regurgitation: A Narrative Review.

Rev Cardiovasc Med

August 2025

Department of Pharmacy, University of Pisa, 56126 Pisa, Italy.

Sara Veneziano , Sabrina Trippoli , Andrea Messori , Vincenzo Calderone , Eugenia Piragine

Medical devices for tricuspid regurgitation have emerged as viable treatment options for patients who do not respond to drug therapy or who are unsuitable for open-heart surgery due to high surgical risk. Recently, numerous new medical devices have been proposed and approved for use. Therefore, comprehensive reviews of the literature on the current medical devices for tricuspid regurgitation are necessary.

View Article and Find Full Text PDF
Similar Publications

Transcatheter versus minimally invasive surgical aortic valve replacement: A propensity score-matched analysis in low-risk patients.

JTCVS Open

August 2025

St Joseph's Hospital Medical Center, Syracuse, NY.

Mark R Lutz , Shaelyn M Cavanaugh , Samuel J Martin , Anna Gleboff , Karikehalli Dilip

Objective: Minimally invasive aortic valve replacement (MIAVR) and transcatheter aortic valve replacement (TAVR) represent less-invasive alternatives to conventional surgical aortic valve replacement. In contrast to Society of Thoracic Surgeons (STS) Database data revealing <10% of all surgical aortic valve replacement procedures are performed via a minimally invasive approach, our center performs a high volume of MIAVR procedures. This propensity-score matched study aims to compare the outcomes of MIAVR versus TAVR in low-risk patients (STS Predicted Risk of Mortality <4%).

View Article and Find Full Text PDF
Similar Publications

Transcatheter Edge-to-Edge Repair of Severe Tricuspid Regurgitation With a Large Coaptation Gap Facilitated by VA-ECMO.

JACC Cardiovasc Interv

September 2025

Structural Heart & Valve Center, Houston Heart, HCA Houston Healthcare Medical Center, Houston, Texas, USA. Electronic address:

Aswin Srinivasan , Mukhtar Al-Saadi , Alexander Rhodes , Arnav Kumar , Pranav Loyalka

View Article and Find Full Text PDF
Similar Publications
Privacy Policy Site Map

© LitMetric 2025. All rights reserved.